ScholarIQanswers from OpenAlex & ORCID
Silvio Veronese
ResearcherPublications, citations & collaboration network
Silvio Veronese is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Silvio Veronese have?
ScholarIQindexed works
Silvio Veronese has 230 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Silvio Veronese have?
ScholarIQcitation count
Silvio Veronese has 18,671 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Silvio Veronese?
ScholarIQh-index
Silvio Veronese has an h-index of 45 in OpenAlex.
What is the i10-index of Silvio Veronese?
ScholarIQi10-index
Silvio Veronese has an i10-index of 85 in OpenAlex.
What is the ORCID of Silvio Veronese?
ScholarIQorcid
The ORCID for Silvio Veronese is on the source record.
What is the OpenAlex record for Silvio Veronese?
ScholarIQopenalex
The OpenAlex for Silvio Veronese is on the source record.
What are the most-cited papers on Silvio Veronese?
ScholarIQmost cited works
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda, Mark Sausen, Rebecca Leary, Isaac Kinde, Yuxuan Wang, Nishant Agrawal, Bjarne R. Bartlett, Hao Wang, Brandon Luber, Rhoda M. Alani, Emmanuel S. Antonarakis, Nilofer S. Azad, Alberto Bardelli, Henry Brem, John L. Cameron, Clarence Lee, Leslie A. Fecher, Gary L. Gallia, Peter Gibbs, Dung T. Le, Robert Giuntoli, Michael Goggins, Michael D. Hogarty, Matthias Holdhoff, Seung‐Mo Hong, Yuchen Jiao, Hartmut Juhl, Jaeyeon Kim, Giulia Siravegna, Daniel A. Laheru, Calogero Lauricella, Michael Lim, Evan J. Lipson, Suely Kazue Nagahashi Marie, George J. Netto, Kelly S. Oliner, Alessandro Olivi, Louise Olsson, Gregory J. Riggins, Andrea Sartore‐Bianchi, Kerstin Schmidt, le-Ming Shih, Sueli Mieko Oba‐Shinjo, Salvatore Siena, Dan Theodorescu, Jeanne Tie, Timothy T. Harkins, Silvio Veronese, Tian‐Li Wang, Jon Weingart, Christopher L. Wolfgang, Laura D. Wood, Dongmei Xing, Ralph H. Hruban, Jian Wu, Peter J. Allen, C. Max Schmidt, Michael A. Choti, Victor E. Velculescu, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Luis A. Díaz
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
Andrea Sartore‐Bianchi, Livio Trusolino, Cosimo Martino, Katia Bencardino, Sara Lonardi, Francesca Bergamo, Vittorina Zagonel, Francesco Leone, Ilaria Depetris, Erika Martinelli, Teresa Troiani, Fortunato Ciardiello, Patrizia Racca, Andrea Bertotti, Giulia Siravegna, Valter Torri, Alessio Amatu, Silvia Ghezzi, Giovanna Marrapese, Laura Palmeri, Emanuele Valtorta, Andrea Cassingena, Calogero Lauricella, Angelo Vanzulli, Daniele Regge, Silvio Veronese, Paolo M. Comoglio, Alberto Bardelli, Silvia Marsoni, Salvatore Siena